An interim analysis of the results of treatment program implementation with the use of injectable extended-release naltrexone for opioid addicted patients

0Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective. To analyze outcomes of treatment in the «Point of soberness» program for opioid addicted patients (2015—2016 гг.). Material and methods. The results of treatment of 83 opioid addicted patients were analyzed. Seventy-four (89.16%) patients received treatment course of injections of extended-release naltrexone (from 4 to 6 injections), maintaining their participation in the outpatient medical rehabilitation program. Thirty-six (43.37%) patients completed a full course of injections of extended-release naltrexone. Results and conclusion. The high efficacy of complex treatment with naltrexone injections was demonstrated. 89% of patients achieved remission during the course of treatment.

Cite

CITATION STYLE

APA

Agibalova, T. V., Nedobylskiy, O. V., Poplevchenkov, K. N., Sirotko, I. I., Shcherban, A. V., & Tsarev, S. A. (2017). An interim analysis of the results of treatment program implementation with the use of injectable extended-release naltrexone for opioid addicted patients. Zhurnal Nevrologii i Psihiatrii Imeni S.S. Korsakova, 117(6), 32–34. https://doi.org/10.17116/jnevro20171176132-34

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free